Guillain‐Barré syndrome following COVID‐19 vaccination: An updated systematic review of cases
<h3>Key Clinical Message</h3><p dir="ltr">Guillain‐Barré syndrome (GBS) is a rare but possible complication that may occur after COVID‐19 vaccination. In this systematic review, we found that GBS presented in patients with an average age of 58. The average time for sympto...
محفوظ في:
| المؤلف الرئيسي: | Nour Shaheen (14034758) (author) |
|---|---|
| مؤلفون آخرون: | Abdelraouf Ramadan (17687433) (author), Abdulqadir J. Nashwan (11659453) (author), Ahmed Shaheen (15205087) (author), Shahzaib Ahmad (16676910) (author), Karam R. Motawea (13954362) (author), Salaheldin Mohamed (21397952) (author), Rahma Sameh Mohamed (21397955) (author), Sarya Swed (12331238) (author), Hani Aiash (12324223) (author) |
| منشور في: |
2023
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Post-COVID-19 vaccine Guillain-Barré syndrome; first reported case from Qatar
حسب: Almurtada Razok (12204854)
منشور في: (2021) -
COVID-19 infection presented as Guillain-Barre Syndrome: Report of two new cases and review of 116 reported cases and case series
حسب: Abdel-Naser Elzouki (9376853)
منشور في: (2021) -
Atypical Guillain–Barre syndrome with T6 sensory level
حسب: Osamah Al‐Ameen (21383678)
منشور في: (2022) -
Kikuchi-Fujimoto disease following SARS CoV2 vaccination: Case report
حسب: Hussam Al Soub (17269024)
منشور في: (2021) -
COVID-19Base v3: Update of the knowledgebase for drugs and biomedical entities linked to COVID-19
حسب: Syed Abdullah Basit (18021787)
منشور في: (2023)